26 Validation of the Primary Immune Response (PIR) test in advanced non-small cell lung cancer (NSCLC): blinded retrospective analyses from the POPLAR and OAK trials

Geahča maid

• 26 Validation of the Primary Immune Response (PIR) test in advanced non-small cell lung cancer (NSCLC): blinded retrospective analyses from the POPLAR and OAK trials
  Dahkki: Joanna Roder, et al.
  Almmustuhtton: (2021-11-01)
• Development and validation of a serum proteomic test for predicting patient outcomes in advanced non-small cell lung cancer treated with atezolizumab or docetaxel
  Dahkki: Joanna Roder, et al.
  Almmustuhtton: (2025-05-01)
• 831 Exact Shapley values for explaining complex machine learning based molecular tests of checkpoint inhibitors: potential utility for patients, physicians, and translational research
  Dahkki: Joanna Roder, et al.
  Almmustuhtton: (2021-11-01)
• Semi-Quantitative MALDI Measurements of Blood-Based Samples for Molecular Diagnostics
  Dahkki: Matthew A. Koc, et al.
  Almmustuhtton: (2022-02-01)
• Explaining multivariate molecular diagnostic tests via Shapley values
  Dahkki: Joanna Roder, et al.
  Almmustuhtton: (2021-07-01)